Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
10/2012
10/24/2012EP2514740A1 Deuterated O-desmethylvenlafaxines with serotoninergic and/or norepinephrinergic activity
10/24/2012EP2513069A1 Antifungal compounds
10/24/2012CN102753537A Method for the preparation of rivaroxaban
10/24/2012CN102753520A N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
10/24/2012CN102746288A Preparation methods of anticoagulant and key intermediate of anticoagulant
10/24/2012CN102746251A 7-oxa-4-aza-spiro[2,5] octane derivative and preparation method thereof
10/23/2012US8293945 Method for producing an amine
10/18/2012WO2012140061A1 Method for the preparation of substituted oxazolidinones
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012094622A3 Amination of aryl alcohol derivatives
10/18/2012US20120264933 Efficient process to induce enantioselectivity in procarbonyl compounds
10/18/2012US20120264834 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/17/2012EP2511269A1 Fused heterocyclic compound having amino group
10/17/2012EP2511268A1 Oxazine derivative
10/17/2012EP2511264A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/17/2012EP2509966A1 Amino oxazine derivatives
10/17/2012EP2509965A1 2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors
10/17/2012EP2509941A2 N-acylated hydroxylamine derivatives and o-acylated hydroxylamine derivatives
10/17/2012EP2509940A2 Amyloid binding agents
10/17/2012CN102127031B Ephedrine compound quaternary ammonium and synthetic method and application thereof
10/16/2012US8288533 Methods for preparing benzoxazines using aqueous solvent
10/16/2012US8287775 Photochromic material
10/11/2012WO2012136655A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258961 4-amino-1,3-thiazine or oxazine derivative
10/10/2012EP2508186A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/10/2012EP2507210A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
10/10/2012CN102725275A Bisbenzoxazinone compound
10/10/2012CN102725268A Compounds for electronic devices
10/10/2012CN101928257B Isatoic acid anhydride synthesis method
10/09/2012CA2537355C Condensed ring compound and use thereof
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120252801 Antifungal compounds
10/03/2012EP2505585A1 Bis-benzoxazinone compound
10/03/2012CN102712609A 2-Amino-5,5-difluoro-5,6-dihydro-4h-oxazines as BACE1 and/or BACE2 inhibitors
10/03/2012CN102702129A Ester-group-containing diamine type fluorenyl benzoxazine
10/03/2012CN102702128A Ether bond-containing diamine flourenyl benzoxazine
10/03/2012CN101845009B Structural carotenoid analogs for the inhibition and amelioration of disease
10/03/2012CN101679324B Morpholine derivative
10/02/2012US8278489 Method for producing an amine
09/2012
09/27/2012WO2012128582A2 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
09/27/2012WO2012127388A1 Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012WO2012127385A1 Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012WO2012126922A1 Heterocyclic amine derivatives
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012031298A3 Ethynylbenzene derivatives
09/27/2012US20120245163 TRPV1 Antagonists
09/27/2012US20120245157 Oxazine derivatives
09/27/2012US20120245155 Fused heterocyclic compound having amino group
09/27/2012US20120245137 Aryl sulphone derivatives as calcium channel blockers
09/27/2012CA2829466A1 Benzo [b] [1,4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012CA2828283A1 Heterocyclic amine derivatives
09/26/2012CN102105455B valiolamine of Stereoselective synthesis voglibose key intermediate
09/26/2012CN101808616B Hair dye and hair dye composition
09/25/2012CA2560071C Lysine based compounds
09/20/2012WO2012124775A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012WO2012124719A1 Polymerizable compound, polymerizable liquid crystal composition, polymeric compound, and film
09/20/2012CA2828378A1 Nitrogen-containing saturated heterocyclic compound
09/19/2012EP2498599A1 Analgesic that binds filamin a
09/19/2012CN102686563A Substituted benzamide derivatives
09/19/2012CN102675489A Benzoxazine structure-containing benzophenone photoinitiator and preparation method thereof
09/19/2012CN102675240A 4-substitute-2-hydroxy morpholine-3-one and preparation method thereof
09/19/2012CN102675125A Simple, convenient and high-efficiency synthesis method of 4-chloro-2-trifluoroacetylaniline and analogs thereof
09/19/2012CN101796039B Phenylacetic acid compound
09/18/2012US8268995 Processes for preparing amines and catalysts for use therein
09/18/2012US8268820 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/18/2012US8268014 Hair dyeing composition
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/13/2012WO2012120476A1 Substituted morpholines as modulators for the calcium sensing receptor
09/13/2012WO2012120423A1 Pharmaceutical composition for the prevention or treatment of cancers
09/13/2012WO2012119927A1 Method for producing primary amines obtained by homogeneously catalyzed alcohol amination
09/13/2012US20120232267 Process for continuous hydrogenation or hydrogenating amination
09/13/2012US20120232266 Reduction of organic compounds with low amounts of hydrogen
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232069 Process for preparing efavirenz polymorph
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120231952 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides
09/13/2012CA2828415A1 Substituted morpholines as modulators for the calcium sensing receptor
09/13/2012CA2828166A1 Process for the preparation of primary amines by homogeneously catalyzed alcohol amination
09/12/2012CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders
09/11/2012US8263593 Therapeutic compounds
09/11/2012US8263591 Bicyclic amides for enhancing glutamatergic synaptic responses
09/06/2012US20120225121 Bioequivalent formulation of efavirenz
09/05/2012CN102656714A Organic electroluminescent element
09/05/2012CN102656148A Cyclic hydroxylamine derivatives, their preparation and use as antioxidants
09/05/2012CN102653511A 3,5-diaryl benzene ring ether derivate as well as preparation method and application thereof
09/05/2012CN101878201B Fused indane compound
09/05/2012CN101679629B Benzoxazine-formulations with reduced outgassing behaviour
09/04/2012US8258131 Fused bicyclic compound
09/04/2012US8257448 Hair dyeing composition
09/04/2012CA2506716C Carboxamides
08/2012
08/30/2012US20120220768 Process of forming an amide
08/30/2012US20120220577 Glycine b antagonists
08/30/2012US20120220552 (thio)morpholine derivatives as s1p modulators
08/29/2012EP2492988A1 Organic electroluminescent element
08/29/2012EP2491030A1 Fused ring analogues of anti-fibrotic agents
08/29/2012CN102652129A Amino oxazine derivatives
08/29/2012CN102020615B Morpholone derivative and preparation method thereof
08/29/2012CN101578274B Method for producing betamimetics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 112